Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Sherbrooke

$13,224.00

Studies to improve bone augmentation procedures using injectable biomaterials

FY 2017-18

Summary
There are currently no effective therapies for Vertebral Fractures VF, the most common complications of osteoporosis. The mortality rate associated with VF is reported to be 8%. Since the VF incidence is expected to escalate as the population ages, it is essential to find solutions. Bone augmentation is a novel procedure to treat bone fractures. In it, a self-hardening cementitious polymethyl methacrylate PMMA, percutaneously injected into the porous structure of the bone. The PMMA, once hardened, stabilizes the fractured bone. The main benefit is that the patient experiences relief from pain, almost immediately after the procedure, at a fraction of the cost of other surgical treatments. The research program is delineated in 3 projects to address 3 major challenges of the procedure. The 1st challenge is the mismatch of the stiffness of the hardened PMMA cement and bone, causing high stresses in the adjacent bone. Higher stresses can lead to new adjacent damage or migration of the PMMA. The 1st objective is to aerate the viscoelastic PMMA paste, with sterile air, to reduce this mismatch. Specifically, the air-containing mixture produces porous cement and its stiffness can be adapted by the percentage of contained air. The solution, considering the issue of new materials facing regulatory challenges, resides in a mixing device. Calcium phosphate CP is a material recently introduced to address the biological shortcoming of PMMA. Yet, CP comes with new injection problems. The 2nd objective is to vibrate and fluidize the CP particle paste to prevent the suspending liquid phase from separating from the CP particle paste, which results in a non-uniform CP paste extrudate. As a result of the vibrofluidization, the liquid and paste may remain percutaneously injectable and the extrudate homogeneous. The 3rd challenge is the inability of physicians to intraoperatively evaluate the trabecular bone strength, which largely defines the vertebral strength and stability of transpedicular screws that are essential for anchoring a multi-component mechanical construct in the osteoporotic spine. The decision is made subjectively whether or not to augment the transpedicular screws. The 3rd objective is to develop a percutaneous indentation process, in which the trabecular bone is considered as a porous solid, and to use a rigid probe to objectively measure its strength. The research program comprises both computational and experimental methods to effectively study the physical and geometric interactions in the 3 objectives. The expected outcomes will be 3 novel medical technologies : a piezo-instrumented syringe, an aeration mixer, and a bone strength probe to reliably screen patients for osteoporosis. The prime beneficiaries are patients suffering from bone fractures. The socioeconomic impact of these developments is potential health care savings and commercial exploitation of devices by the medical industry.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2015-05437
Name nom
Baroud, Gamal
Department département
Génie mécanique - Génie mécanique
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2015
Award amount
13224
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1512
Committee name en
Mechanical Engineering
Committee name fr
Génie mécanique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1903
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomechanics
Research subject fr
Biomécanique
Partie
3
Nb partie
5
Application title
Studies to improve bone augmentation procedures using injectable biomaterials
Keyword
NSERC
Application summary
There are currently no effective therapies for Vertebral Fractures VF, the most common complications of osteoporosis. The mortality rate associated with VF is reported to be 8%. Since the VF incidence is expected to escalate as the population ages, it is essential to find solutions. Bone augmentation is a novel procedure to treat bone fractures. In it, a self-hardening cementitious polymethyl methacrylate PMMA, percutaneously injected into the porous structure of the bone. The PMMA, once hardened, stabilizes the fractured bone. The main benefit is that the patient experiences relief from pain, almost immediately after the procedure, at a fraction of the cost of other surgical treatments. The research program is delineated in 3 projects to address 3 major challenges of the procedure. The 1st challenge is the mismatch of the stiffness of the hardened PMMA cement and bone, causing high stresses in the adjacent bone. Higher stresses can lead to new adjacent damage or migration of the PMMA. The 1st objective is to aerate the viscoelastic PMMA paste, with sterile air, to reduce this mismatch. Specifically, the air-containing mixture produces porous cement and its stiffness can be adapted by the percentage of contained air. The solution, considering the issue of new materials facing regulatory challenges, resides in a mixing device. Calcium phosphate CP is a material recently introduced to address the biological shortcoming of PMMA. Yet, CP comes with new injection problems. The 2nd objective is to vibrate and fluidize the CP particle paste to prevent the suspending liquid phase from separating from the CP particle paste, which results in a non-uniform CP paste extrudate. As a result of the vibrofluidization, the liquid and paste may remain percutaneously injectable and the extrudate homogeneous. The 3rd challenge is the inability of physicians to intraoperatively evaluate the trabecular bone strength, which largely defines the vertebral strength and stability of transpedicular screws that are essential for anchoring a multi-component mechanical construct in the osteoporotic spine. The decision is made subjectively whether or not to augment the transpedicular screws. The 3rd objective is to develop a percutaneous indentation process, in which the trabecular bone is considered as a porous solid, and to use a rigid probe to objectively measure its strength. The research program comprises both computational and experimental methods to effectively study the physical and geometric interactions in the 3 objectives. The expected outcomes will be 3 novel medical technologies : a piezo-instrumented syringe, an aeration mixer, and a bone strength probe to reliably screen patients for osteoporosis. The prime beneficiaries are patients suffering from bone fractures. The socioeconomic impact of these developments is potential health care savings and commercial exploitation of devices by the medical industry.
Université de Sherbrooke - $13,224 Grant (2017-18) | Canada Spends